share_log

Plus Therapeutics | 8-K: Plus Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Business Highlights

SEC ·  Feb 24, 2023 05:10
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.